Insight Brief

6 Key Elements of Successful Companion Diagnostic Development

Successful Companion Diagnostic Development: Current trends and recommendations

With a growing shift toward personalized medicine therapies, particularly in oncology, developing a companion diagnostic (CDx) strategy is pivotal to improve drug development and patient care. 

Read our complimentary insight brief to learn how current trends and recommendations for successful CDx development are changing the way drug developers, IVD manufacturers and laboratories work together to achieve success for patients.

Contact us to learn how we can advance your immuno-oncology drug development program.


More Resources

2 Essential Approaches You Should be Using Now for Minimal Residual Disease Detection in Oncology
Benefits of Genomic Testing in Immuno-oncology Clinical Trials
4 Ways Central Laboratories Shape Immuno-oncology Drug Development
View All